Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Derived from a naturally occurring gastric protein fragment, BPC-157 is recognized for its stability and broad range of experimental research applications
A literature review of human studies from 2014 to 2024 examining glutathione therapy in non-alcoholic fatty liver disease (NAFLD) found consistent improvements in alanine transaminase (ALT) levels and reductions in oxidative stress markers in subjects receiving glutathione as the primary intervention
Reconstitute with bacteriostatic water for research handling
The nasal route facilitates non-invasive administration, avoiding the need for injections or complex delivery systems, which may simplify protocol designs during experimental procedures
US$ 26.53
US$ 22.30
US$ 28.28
US$ 26.95
US$ 24.63
US$ 28.55
